Unilife Corporation (UNIS) is Upgraded by Griffin Securities to Buy, Price Target at $1.50

Unilife Corporation (UNIS) is Upgraded by Griffin Securities to Buy according to the research report released to the investors. The brokerage firm has set the Price Target of the shares at $1.50. Earlier the firm had a rating of Hold on the company shares. The shares recommendation by the Brokerage Firm was released on Jan-4-2016.

Unilife Corporation has dropped 47.66% during the last 3-month period . Year-to-Date the stock performance stands at -85.22%.The company shares have dropped -84.66% from its 1 Year high price. On Jan 27, 2015, the shares registered one year high at $4.90 and the one year low was seen on Dec 29, 2015. The 50-Day Moving Average price is $0.69 and the 200 Day Moving Average price is recorded at $1.24.

Unilife Corporation (NASDAQ:UNIS) has lost 0.98% during the past week and dropped 30.95% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 0.15%. Unilife Corporation (NASDAQ:UNIS) has underperformed the index by 29.34% in the last 4 weeks. Investors should watch out for further signals and trade with caution.

Shares of Unilife Corporation (NASDAQ:UNIS) ended Thursday session in red amid volatile trading. The shares closed down 0.0278 points or 5.32% at $0.4951 with 1,202,413 shares getting traded. Post opening the session at $0.5, the shares hit an intraday low of $0.42 and an intraday high of $0.54 and the price vacillated in this range throughout the day. The company has a market cap of $69 million and the number of outstanding shares have been calculated to be 139,246,950 shares. The 52-week high of Unilife Corporation (NASDAQ:UNIS) is $4.9 and the 52-week low is $0.42.

Currently the company Insiders own 8.4% of Unilife Corporation shares according to the proxy statements. Institutional Investors own 32.72% of Unilife Corporation shares. During last six month period, the net percent change held by insiders has seen a change of -2.15%. On a different note, The Company has disclosed insider buying and selling activities to the Securities Exchange, Pyers Dennis, officer of Unilife Corp, unloaded 10,000 shares at an average price of $1.17 on September 15, 2015. The total amount of the transaction was worth $11,700, according to the disclosed information with the Securities and Exchange Commission in a Form 4 filing.

Unilife Corporation (Unilife) is a developer, manufacturer and supplier of injectable drugs delivery systems. The Company manufactures and supplies its devices to pharmaceutical companies in a format where they can be filled and packaged with an injectable therapy prior to its shipment to the end-user. The Companys technology platforms cover six device categories: Prefilled Syringes, Drug Reconstitution Delivery Systems, Auto-Injectors, Wearable Injectors, Ocular Delivery Systems and Delivery Systems.